Objectives-To assess the effectiveness of atrial septostomy by percutaneous balloon dilatation in patients with congenital heart defects or primary pulmonary hypertension. Patients and design-Twenty three patients (15 boys, eight girls; aged 10 days to 10 years; 17 with congenital heart defects and six with primary pulmonary hypertension), all haemodynamically unstable under optimal medical treatment, underwent atrial septostomy by percutaneous balloon dilatation. Interventions-The balloon catheter entered the left atrium through a patent foramen ovale (n = 14) or via transseptal puncture in cases with an intact atrial septum (n = 9). The size of the balloons used ranged from 13 to 18 mm. Results-There were no complications. The interatrial communication (mm) increased (P < 0.05) after dilatation and remained unchanged (P = NS) during a 16-6 (13-8) month follow up (2 (1.7) v 8-8 (1.4) v 8'2 (1.1), respectively). Transatrial gradient (mm Hg) fell and arterial oxygenation (%) improved both in patients with transposition (6.3 (0.8) v 0-8 (1)(P = 0.0001) and 40*6 (4.2) v 76 5 (4.8) (P = 0.0001), respectively) and in those with mitral atresia (13.4 (1.9) v 2 (1.4) (P = 0.0001) and 77-1 (3.9) v 81-5 (4.2) (P = 0.008), respectively). There were two failures, one early and one late, both in the group of patients with mitral atresia or stenosis. A decrease in arterial oxygenation (94.8 (1.5) v 83 (2.4), P = 0.004) and an increase in left atrial pressure (6.8 (0.9) v 8-3 (1.2), P = 0*02) and cardiac index (2.3 (0.2) v 3-1 (0.2) lminlm2, P = 0.002) was observed in patients with primary pulmonary hypertension. Conclusions-Percutaneous balloon dilatation is an effective and safe procedure for creating an adequate interatrial communication that can be used as an alternative to blade septostomy. (Heart 1996;76:502-506) 
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trepeat procedure. (fig 1 B) . The balloon diame- (1.4) mm Hg (P = 0-0001) in patients with mitral atresia or stenosis (fig 2A and B) . A total of three patients in those two groups had an intact interatrial septum and needed a transseptal puncture. In these cases the transatrial gradient was not measured because it was not possible to do a pull-back measurement. The same applied to the group of six patients with primary pulmonary hypertension. group.bmj.com on June 22, 2017 -Published by http://heart.bmj.com/ Downloaded from 2 shows the haemodynamic results of this group. Mean right atrial pressure decreased slightly but not significantly (P = NS) from 11 3 (3 5) mm Hg (range 7 to 17 mm Hg) before to 9 (1-5) mm Hg (range 7 to 77 mm Hg) immediately after the procedure, whereas left atrial pressure increased from 6-8 (0 9) mm Hg (range 6 to 8 mm Hg) to 8-3 (1P2) mm Hg (range 7 to 10 mmHg) (P = 002) and cardiac index increased from 2-3 (0 2) 1/min/m2 to 3 1 (0 2) 1/min/m2 (P = 0 002).
Pulmonary arteriolar resistance, as expected, was not affected by balloon atrial septostomy (preprocedural 22-8 (3'8) units/M2; postprocedural (2 7) units/M2; P = NS). The patient with tricuspid atresia had a predilatation interatrial gradient of 4 mm Hg, which fell to 1 mm Hg postdilatation.
FOLLOW UP
The mean diameter of the interatrial communication at follow up was not significantly different from that obtained immediately after the procedure (8-8 (1P4) mm v 8-2 (1P1) mm, respectively (P = NS)). Moreover, the mean diameter of interatrial communication at follow up was not significantly different in patients with an intact or a non-intact septum before the procedure (8-4 (1-3) mm v 9-1 (1 6) mm, respectively, P = NS).
There was one patient in the mitral atresia/ stenosis group (case 10) in whom the size of the communication had decreased to its preseptostomy value (5 mm) eight months after the initial procedure. Echocardiography in this patient showed signs of left atrial dilatation with the interatrial septum bulging to the right. As there was also some degree of pulmonary congestion on the chest x ray it was decided to repeat the procedure with a 18 mm balloon instead of the 15 mm which was used the first time. The transatrial pressure gradient fell from 10 to 2 mm Hg and the size of the communication increased from 5 to 9 mm. The arterial oxygen saturation increased from 78% to 83%. At the last follow up, one month after the second dilatation, the patient was doing well and the interatrial communication as measured at echocardiography was 9 mm. All patients with primary pulmonary hypertension showed a significant improvement in symptoms and had no further syncopal episodes; they showed a steady improvement in exercise tolerance. 18 The introduction of balloon atrial septostomy has greatly improved the prognosis of patients with transposition of the great arteries; three month survival has increased from 20% to 85%.'9 But beyond the neonatal period, the lower margin of the patent foramen ovale is thick and muscular20 and cannot be ruptured by Rashkind's balloon, leading to failure of this technique in older infants and children. 21 To circumvent this problem, Park et all developed a catheter with a built-in retractable blade to cut the lower margin of the foramen ovale. Although this technique has had good success rates, ranging from 70% to 90%,3 it can cause fatal complications especially when the left atrium is small.56
Atrial septostomy by percutaneous balloon dilatation was first described in 1986 by Mitchell et al22 in an experimental model. In 1987 it was first used in an infant by Shrivastava et al. 8 Subsequently, a few children, needing for various reasons, an interatrial communication have been treated with this tecnique.69"
In this study, of what we believe to be the largest group of patients treated with this method and with the longest follow up, the technique was beneficial and safe in nearly all our patients. It was unsuccessful in two patients:case 10 who had a repeat septostomy and case 14 who had a blade septostomy. In the transposition group the arterial oxygen saturation increased significantly which enabled all seven infants to wait for subsequent Senning or Musterd operations. In the group with complex congenital heart diseases with mitral atresia or stenosis, percutaneous balloon dilatation of the atrial septum was associated with significant decompression of the left atrium in eight out of nine patients, as indicated by the lowering of the transatrial gradient and the increase in arterial oxygen saturation after the procedure.
In the six patients with primary pulmonary hypertension, the creation of the interatrial communication relieved symptoms (no more syncopal episodes or cyanotic spells and improved exercise tolerance), with a moderate drop in the arterial oxygen saturation.
The after the initial balloon dilatation, but our data suggest that this may be unecessary. Failure may occur when the atrial septum is very thick,9 10 no matter what technique is used, and a small percentage of patients will require surgical septostomy.
Hausknecht et al 12 and Rotman et al 3 were the first to use balloon dilatation of the atrial septum for palliation of two patients with primary pulmonary hypertension. Both were significantly improved and one of them had a successful single lung transplantation 13 months later. As the procedure is not without risks in this setting, particularly when the pulmonary arteriolar resistance is very high, Nihill et al II recommend that it should be avoided in cases with pulmonary arteriolar resistance of more than 50 units/M2. None of our patients exceeded this level, and, based on our limited experience, we believe that an atrial opening of 7-8 mm is ideal. This was achieved by initially employing a 13 mm balloon, and after reassessment of haemodynamics the procedure was completed with a 15 mm or 18 mm balloon. Another variable that should be considered is the fall in arterial oxygen saturation. According to Rich et al24 a saturation of less than 72% is associated with high mortality. In our cases we aimed at a systemic oxygen saturation of between 80% and 85%, as did Rotman et al,"3 and finally we achieved saturations of 79% to 86%.
In conclusion, balloon dilatation of the atrial septum is an effective and safe procedure for creating long lasting atrial communications that can be used as an alternative to
